SCHEMBL9830302

SCHEMBL9830302

CCCCCCCCC(=O)NC(CCC(=O)O)C(=O)O

nearest known ligand 0.82

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ NOD1 Q9Y239 9/20 0.82
▸ PLA2G2C Q5R387 1/20 0.67
▸ PLA2G10 O15496 2/20 0.61
▸ SLC6A5 Q9Y345 2/20 0.60
▸ FAAH O00519 2/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ FOLH1 Q04609 1/20 0.55
▸ RIMKLA Q8IXN7 1/20 0.55
▸ NAALAD2 Q9Y3Q0 1/20 0.55
▸ EPHX2 P34913 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15846850 1.00 NOD1 (0.82) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL526043 1.00 NOD1 (0.82) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL543273 1.00 NOD1 (0.82) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL18038484 1.00 NOD1 (0.82) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL543291 1.00 NOD1 (0.82) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL19049827 1.00 NOD1 (0.82) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL9830306 1.00 NOD1 (0.82) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL17204092 1.00 NOD1 (0.82) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL10829302 1.00 NOD1 (0.82) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL3174181 1.00 NOD1 (0.82) NOD1PLA2G2CPLA2G10SLC6A5FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250000948-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID ADOCIA (FR) 2025-01-02 — — US disclosed
EP-4433093-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID Adocia (FR) 2024-09-25 — — EP disclosed
EP-4299057-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID Adocia (FR) 2024-01-03 — — EP disclosed
WO-2023084118-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID ADOCIA (FR) 2023-05-19 — — WO disclosed
US-11246823-B2 Molecularly imprinted polymer of sol-gel type for selectively trapping odorous molecules L'OREAL (FR) 2022-02-15 — — US disclosed
US-10772823-B2 Molecularly imprinted polymer for selectively trapping odorous molecules L'OREAL (FR) 2020-09-15 — — US disclosed
EP-2938654-B1 MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES OREAL (FR) 2016-08-24 — — EP disclosed
US-20150342868-A1 MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES LOREAL (FR) 2015-12-03 — — US disclosed
US-20150320667-A1 MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES L'OREAL (FR) 2015-11-12 — — US disclosed
EP-2938654-A1 MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES L'OREAL (FR) 2015-11-04 — — EP disclosed
EP-2938402-A1 MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES L'OREAL (FR) 2015-11-04 — — EP disclosed
WO-2014102077-A1 MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES L'OREAL (FR) 2014-07-03 — — WO disclosed
WO-2014102078-A1 MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES L'OREAL (FR) 2014-07-03 — — WO disclosed
EP-0226304-B1 COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC SANKYO COMPANY LIMITED (JP) 1991-08-28 — — EP disclosed
US-4757066-A Reduces renal toxicity SANKYO COMPANY LIMITED (JP) 1988-07-12 — — US disclosed
EP-0226304-A1 Composition containing a penem or carbapenem antibiotic SANKYO COMPANY LIMITED (JP) 1987-06-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250000948-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID NPPA, BCAT1, ANPEP NOD1 3434/4885PLA2G2C 433/4885PLA2G10 1684/4885
US-11246823-B2 Molecularly imprinted polymer of sol-gel type for selectively trapping odorous molecules TAS2R30, TAS1R1, TAS2R10 NOD1 4516/4885PLA2G2C 2147/4885PLA2G10 1999/4885
US-20150342868-A1 MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES TAS2R30, TAS1R1, TAS2R10 NOD1 4516/4885PLA2G2C 2147/4885PLA2G10 1999/4885
US-10772823-B2 Molecularly imprinted polymer for selectively trapping odorous molecules OR10J3, OR51E2, MSMO1 NOD1 4482/4885PLA2G2C 3502/4885PLA2G10 3609/4885
US-20150320667-A1 MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES OR10J3, OR51E2, MSMO1 NOD1 4482/4885PLA2G2C 3502/4885PLA2G10 3609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback